For patients with chronic sciatica, gabapentin is superior to pregabalin, with fewer and less severe adverse events.
The Centers for Disease Control and Prevention's "Guideline for Prescribing Opioids for Chronic Pain" may have contributed to a further reduction in several opioid prescribing practices.
Considerable proportion of healthy individuals without back pain have MRI positive for sacroiliitis.
Higher prevalence of chronic pain, high-impact chronic pain for women, older adults, rural residents.
In a randomized control trial, researchers found that internet-delivered exposure therapy was more cost-effective for patients with fibromyalgia than a waitlist control, which did not involve any treatment during the experimental phase of the study.
An estimated 31 million Americans will experience low back pain at some point in their lifetime.
Recall due to mismarked dosage cup in 4-oz bottles of Children's Advil Suspension Bubble Gum Flavored.
No significant reduction in percentage of patients prescribed opioids after general surgery.
Although literature indicates bidirectional associations between sleep disturbances and pain, few longitudinal studies have examined the role of sleep disturbances in contributing to chronic pain.
Integrating graded in vivo exposure into the management of chronic lower back pain may result in improved treatment efficacy and reduced pain-related fear.
The number of patients prescribed opioids and visiting an emergency department or requiring hospitalization decreased from 2009 to 2015.
Dose-response association with highest odds of opioid-related death with high-dose pregabalin.
A low-literacy, pain self-management program delivered one-on-one by a health educator or in groups with lectures from experts over a period of 6 months may improve chronic pain outcomes.
Differences exist in race and gender in patients with chronic lower back pain, especially in pain sensitivity and severity due to aftersensations from mechanical punctuate pain and deep muscle hyperalgesia.
Findings based on analysis of motorcycle accident victims by helmet use.
Cumulative incidence of opioid-related adverse events was 38.3 per 100,000 prescriptions.
Variation exists in opioid prescribing practices among clinicians in single-hospital systems, which prompts concern about the potential for opioid overprescribing.
There is a lack of evidence supporting the benefits of combination drug therapy over monotherapy for the management of low back pain and sciatica.
This novel agent has low permeability across the blood-brain barrier, which slows its rate of entry into the brain and reduces dopamine release.
Postpartum Pain Management Recommendations From the American College of Obstetricians and GynecologistsJuly 26, 2018
A committee from the American College of Obstetricians and Gynecologists formulated several recommendations for safely managing pain and fatigue in women during the early postpartum period.
Odds of pre-op opioid use up with age 31 to 40 years, tobacco use, illicit drug use, depression.
Only 44 of parents would definitely go to ER if their child had headache that didn't improve with medication.
Radiofrequency denervation, typically used to treat lumbar and cervical zygapophyseal joint pain, has shown efficacy in treating thoracic zygapophyseal joint pain.
American emergency medicine physicians have been taking measures to address the ongoing opioid crisis, which affects emergency departments throughout the country.
Consensus guidelines regarding the use of ketamine for the management of acute pain have been approved.
Surgeon General Jerome M. Adams, M.D., M.P.H., has urged more Americans to carry naloxone, an FDA-approved medication that can be delivered via nasal mist or injection and can temporarily suspend the effects of opioid overdose.
Chronic low back pain (LBP) defined as persistent or fluctuating musculoskeletal pain of lower back and lumbar spine lasting >3 months.
A study assessing the impact of upscheduling of hydrocodone combined medications on APRN practices in Oklahoma revealed significant barriers to effective pain management.
The phase 3 SUMMIT-07 trial assessed the safety, efficacy, and tolerability of a new mu-opioid receptor agonist analgesic in adults with moderate to severe chronic lower back pain.
With the increasing number of patients presenting to surgery with opioid tolerance, clinicians should be familiar with their specific analgesic needs.